Lineage Cell Therapeutics (LCTX) EBT (2010 - 2026)
Lineage Cell Therapeutics' (LCTX) quarterly EBT came in at -$19.3 million in Q1 2026, down 183.83% year-on-year from $23.1 million in Q1 2025, and down 232.06% quarter-over-quarter from -$5.8 million in Q4 2025.
Lineage Cell Therapeutics (LCTX) EBT (2010 - 2026) Analysis & Trends
Lineage Cell Therapeutics' EBT history runs 17 years deep, the most recent figure standing at -$19.3 million for Q1 2026.
- On a quarterly basis, EBT fell 183.83% year-over-year to -$19.3 million in Q1 2026; TTM through Mar 2026 was -$66.5 million, a 253.25% decrease from a year earlier, with the FY2025 full-year figure at -$68.6 million, down 269.43% from the prior year.
- EBT fell to -$19.3 million in Q1 2026 per LCTX's latest filing, from -$5.8 million in the prior quarter.
- Across five years, EBT topped out at -$3.0 million in Q3 2024 and bottomed at -$22.5 million in Q2 2025.
- The 5-year median for EBT is -$6.4 million (2022), against an average of -$8.3 million.
- Across the five-year window, EBT soared 77.29% in 2022 and sank 528.02% in 2025, its largest moves.
- Year by year, EBT stood at -$6.4 million in 2022, then gained by 25.9% to -$4.7 million in 2023, then surged by 31.06% to -$3.2 million in 2024, then slumped by 79.11% to -$5.8 million in 2025, then sank by 232.06% to -$19.3 million in 2026.
- Per Business Quant, the three latest LCTX EBT figures stand at -$19.3 million (Q1 2026), -$5.8 million (Q4 2025), and -$18.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | -19.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.33 Mn |
| Dec 31, 2025 | -5.82 Mn |
| Sep 30, 2025 | -18.85 Mn |
| Jun 30, 2025 | -22.54 Mn |
| Mar 31, 2025 | -6.81 Mn |
| Dec 31, 2024 | -3.25 Mn |
| Sep 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -5.77 Mn |
| Mar 31, 2024 | -6.56 Mn |
| Dec 31, 2023 | -4.71 Mn |
| Sep 30, 2023 | -7.16 Mn |
| Jun 30, 2023 | -5.20 Mn |
| Mar 31, 2023 | -6.21 Mn |
| Dec 31, 2022 | -6.36 Mn |
| Sep 30, 2022 | -5.58 Mn |
| Jun 30, 2022 | -6.78 Mn |
| Mar 31, 2022 | -7.09 Mn |
| Dec 31, 2021 | -28.01 Mn |
| Sep 30, 2021 | -8.85 Mn |
| Jun 30, 2021 | -4.97 Mn |